Oor Assertio Therapeutics, Inc.

Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor. Source: Wikipedia
Hoofkantoor251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Gestig2018
StatusAktief

Patente1 patent

GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERSEP2326310B1 · 2019

Deursoek alle patente op Heelky →

Resensies

Nog geen resensies nie. Met Assertio Therapeutics, Inc. gewerk? Wees die eerste om jou ervaring te deel.

Skryf 'n resensie →

Ligging

251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US

Is dit jou maatskappy?

Eis hierdie bladsy gratis op om jou logo, produkte, foto's en poste by te voeg, en om resensies te beantwoord.

Eis hierdie bladsy op

Deel hierdie maatskappy

Assertio Therapeutics, Inc.251 LITTLE FALLS DRIVE, 19808, WILMINGTON, UShttps://heelky.com/explore/companies/assertio-therapeutics-inc-ur37rgl2/

Kopieer skakel

Deel op

QR-kode

Skandeer dit met 'n foon se kamera om hierdie bladsy oop te maak, of laai dit af vir 'n strooibiljet, 'n skyfie of 'n kenteken.

Sluit by Heelky aan om te verbind, aan te stel en te groei

Skep 'n gratis rekening om mense boodskappe te stuur, vir poste aansoek te doen en missies te plaas.

Sluit nou aan — dit is gratis

Kies jou taal

Heelky sal jou keuse onthou.

Ander tale

Beskikbare tale: 70 Oor tale op Heelky